Pharmascience Inc. v. Janssen Inc., 2024 FCA 23
| Jurisdiction | Federal Jurisdiction (Canada) |
| Court | Court of Appeal (Canada) |
| Date | 01 February 2024 |
| Citation | 2024 FCA 23 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
3 practice notes
-
Federal Court Of Appeal Limits Scope Of Prohibition Against Patenting Methods Of Medical Treatment
...matter. Specialist advice should be sought about your specific circumstances. Footnote 1. See Pharmascience Inc. v Janssen Inc. et al, 2024 FCA 23, aff'g 2022 FC The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought abou......
-
Federal Court Of Appeal Affirms Paliperidone Palmitate Claims Are Not Unpatentable Methods Of Medical Treatment
...the invention (i.e., how to use it, not whether to use it) requires the exercise of skill and judgment': Pharmascience Inc v Janssen Inc, 2024 FCA 23. Background The claims of the 335 patent relate to dosing regimens for paliperidone. They contemplate administering specified doses of palipe......
-
Federal Court Of Appeal Addresses Patentability Of Methods Of Medical Treatment In Canada
...subject matter). This distinction has come under scrutiny in recent years.4 The recent FCA decision of Pharmascience v Janssen, 2024 FCA 23 [Janssen], addresses many aspects of the method of medical treatment exception to patentability, including: (i) the history of the exception and its st......
3 firm's commentaries
-
Federal Court Of Appeal Limits Scope Of Prohibition Against Patenting Methods Of Medical Treatment
...matter. Specialist advice should be sought about your specific circumstances. Footnote 1. See Pharmascience Inc. v Janssen Inc. et al, 2024 FCA 23, aff'g 2022 FC The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought abou......
-
Federal Court Of Appeal Affirms Paliperidone Palmitate Claims Are Not Unpatentable Methods Of Medical Treatment
...the invention (i.e., how to use it, not whether to use it) requires the exercise of skill and judgment': Pharmascience Inc v Janssen Inc, 2024 FCA 23. Background The claims of the 335 patent relate to dosing regimens for paliperidone. They contemplate administering specified doses of palipe......
-
Federal Court Of Appeal Addresses Patentability Of Methods Of Medical Treatment In Canada
...subject matter). This distinction has come under scrutiny in recent years.4 The recent FCA decision of Pharmascience v Janssen, 2024 FCA 23 [Janssen], addresses many aspects of the method of medical treatment exception to patentability, including: (i) the history of the exception and its st......